Publication | Open Access
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
537
Citations
46
References
2020
Year
Tumor ImmunologyCancer ImmunosurveillanceT-regulatory CellImmunologyTumor ImmunityAnti-tumour ImmunityImmune Checkpoint InhibitorAutoimmunityT Cell ImmunityCd4+ T CellsCellular Immune ResponseImmune Cell TherapyImmunotherapyMedicineCell BiologyTumor MicroenvironmentTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1